Unichem set to market Chlorthalidone tablets

Unichem Laboratories has announced that the company has received USFDA approval for Chlorthalidone tablets. The product will be commercialised from Unichem's Ghaziabad plant.

The company received ANDA approval from the United States Food and Drug Administration (USFDA) for its Chlorthalidone Tablets USP, 25 mg and 50 mg to market a generic version of Hygroton Tablets, 25 mg and 50 mg of Sanofi Aventis, USA.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Recently, USFDA has conducted an inspection at Unichem Laboratories' Goa formulation facility from July 22 to July 31, 2019. The inspection was a routine GMP surveillance and Post Approval Inspection for the ANDAs submitted from this facility. At the end of Inspection, the facility received four observations, with no repeat observations and are mostly procedural in nature.

The stock is likely to be in focus on Tuesday as on Monday, markets remain closed on accounts of Eid-al-Adha.